Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Ossium Health, Inc.
Orca Biosystems, Inc.
Stanford University
MacroGenics
Janssen Research & Development, LLC
University of Arizona
Case Comprehensive Cancer Center
University of Arizona
City of Hope Medical Center
University of Wisconsin, Madison
Mayo Clinic
Janssen Research & Development, LLC
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Baylor College of Medicine
City of Hope Medical Center
City of Hope Medical Center
American Regent, Inc.
University of Michigan Rogel Cancer Center
Orca Biosystems, Inc.
Tr1X, Inc.
NovaOnco Therapeutics Co., Ltd.
Case Comprehensive Cancer Center
Cyclacel Pharmaceuticals, Inc.
Kyowa Kirin Co., Ltd.
OHSU Knight Cancer Institute
Prelude Therapeutics
Aurigene Discovery Technologies Limited
Beth Israel Deaconess Medical Center
Novo Nordisk A/S
Dartmouth-Hitchcock Medical Center
Melbourne Health
Amgen
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Kansas Medical Center
Prelude Therapeutics
New York Medical College
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Indiana University
M.D. Anderson Cancer Center
Medical College of Wisconsin
Medigene AG
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences